Pharmacy

Your Article Summary

See Latest Articles

In Investigational Studies, New Uses of JANUVIA in Combination with Other Diabetes Medicines Resulted In Significant Blood Sugar-Lowering Efficacy for Patients with Type 2 Diabetes
Merck & Co., 06/08/09

In two new investigational studies evaluating the efficacy and tolerability of Merck and Co., Inc. diabetes medicine JANUVIA, JANUVIA significantly improved blood sugar control. One study evaluated JANUVIA as an addition to ongoing insulin therapy, with or without metformin, and the second evaluated JANUVIA in combination with pioglitazone as an initial treatment regimen. Applications to use JANVUIA in these combinations and JANUMET in combination with insulin have been accepted by the FDA and are currently under review.

Today in Drug Interactions...keeping you current

Receive free subspecialty "5-minute updates" via email

'Party pill' drugs - BZP and TFMPP
New Zealand Medical Journal, 12/14/09

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09

 See all of Drug Interactions

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability
Journal of Pharmacy and Pharmacology, 12/15/09

Novel TNF antagonists for the treatment of rheumatoid arthritis
Expert Opinion on Investigational Drugs, 12/15/09

Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Genentech, 12/15/09

 See all of Other Drugs